» Articles » PMID: 34564578

Effect of Cannabidiol (CBD) on Canine Inflammatory Response: An Ex Vivo Study on LPS Stimulated Whole Blood

Abstract

The use of cannabidiol (CBD) for animal species is an area of growing interest, for example for its anti-inflammatory and immuno-modulating properties, even though all of its biological effects are still not fully understood, especially in veterinary medicine. Therefore, the aim of this study was to investigate the anti-inflammatory and immuno-modulating properties of CBD for the first time directly in canine inflammatory response. We used an ex vivo model of LPS-stimulated whole dog blood. We stimulated the whole blood from healthy dogs with LPS 100 ng/mL for 24 h in the presence or not of CBD 50 and 100 μg/mL. We observed a reduction in IL-6 and TNF-α production from the group treated with CBD, but non-altered IL-10 levels. Moreover, we also observed from the CBD-treated group a reduction in Nf-κB and COX-2 expression. In conclusion, we demonstrated for the first time the anti-inflammatory and immuno-modulating properties of CBD directly in dogs' immune cells, using a canine ex vivo inflammatory model. The results obtained from these studies encourage further studies to better understand the possible therapeutic role of CBD in veterinary medicine.

Citing Articles

Soybean and avocado unsaponifiables: a review of their potential use in the treatment of osteoarthritis.

Sabucedo-Suarez A, Lopez-Pena M, Permuy M, Munoz F Front Vet Sci. 2025; 11:1473688.

PMID: 39881723 PMC: 11776088. DOI: 10.3389/fvets.2024.1473688.


Assessing Facial Thermal Nociceptive Response in Female Dogs After Elective Ovariohysterectomy Anesthetized with Isoflurane and Treated with Cannabidiol and Meloxicam Analgesia.

Casas-Alvarado A, Mora-Medina P, Hernandez-Avalos I, Martinez-Burnes J, Miranda-Cortes A, Dominguez-Oliva A Animals (Basel). 2025; 15(2).

PMID: 39858227 PMC: 11758305. DOI: 10.3390/ani15020227.


Cytotoxicity and Immunomodulatory Effects of Cannabidiol on Canine PBMCs: A Study in LPS-Stimulated and Epileptic Dogs.

Kosukwatthana P, Rungsuriyawiboon O, Rattanasrisomporn J, Kimram K, Tansakul N Animals (Basel). 2025; 14(24.

PMID: 39765588 PMC: 11672443. DOI: 10.3390/ani14243683.


Role of cannabidiolic acid or the combination of cannabigerol/cannabidiol in pain modulation and welfare improvement in horses with chronic osteoarthritis.

Aragona F, Tabbi M, Gugliandolo E, Giannetto C, DAngelo F, Fazio F Front Vet Sci. 2024; 11:1496473.

PMID: 39720409 PMC: 11668182. DOI: 10.3389/fvets.2024.1496473.


in veterinary medicine: Foundations and therapeutic applications.

Pinto K, Requicha J Can Vet J. 2024; 65(9):948-958.

PMID: 39219599 PMC: 11339888.


References
1.
Gamble L, Boesch J, Frye C, Schwark W, Mann S, Wolfe L . Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Front Vet Sci. 2018; 5:165. PMC: 6065210. DOI: 10.3389/fvets.2018.00165. View

2.
Peyravian N, Deo S, Daunert S, Jimenez J . Cannabidiol as a Novel Therapeutic for Immune Modulation. Immunotargets Ther. 2020; 9:131-140. PMC: 7445536. DOI: 10.2147/ITT.S263690. View

3.
Joffre J, Yeh C, Wong E, Thete M, Xu F, Zlatanova I . Activation of CBR Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cells and Reduces Acute Inflammation and Organ Injury. J Immunol. 2020; 204(12):3339-3350. PMC: 7276941. DOI: 10.4049/jimmunol.2000213. View

4.
Atalay S, Jarocka-Karpowicz I, Skrzydlewska E . Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants (Basel). 2019; 9(1). PMC: 7023045. DOI: 10.3390/antiox9010021. View

5.
Jaffey J, Amorim J, DeClue A . Effect of calcitriol on in vitro whole blood cytokine production in critically ill dogs. Vet J. 2018; 236:31-36. DOI: 10.1016/j.tvjl.2018.04.010. View